Fiscal Year 2018 Financial Management Evaluation for Human Drug User Fees Assessment Report

[FDA]

FDA is committed to ensuring user fee resources are administered, allocated, and reported in an efficient and transparent manner. Under PDUFA VI, BsUFA II, and GDUFA II, FDA committed to evaluating the financial administration of these user fee programs to help identify areas to enhance efficiency.


Baca selengkapnya di : http://www.fda.gov...